Medical News

RSS

Researchers to study health literacy among Indigenous people living with cardiovascular disease

Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.

30 Mar 2010

Shinseki tries to squelch rumors about health reform and Vets

Secretary of Veterans Affairs Erik Shinseki "addressed fears that some veterans have expressed that their health care and, specifically, their TRICARE medical coverage will be adversely affected by the health-reform legislation," according to the Providence Journal.

30 Mar 2010

Cephalon receives FDA Complete Response Letter for NUVIGIL supplemental new drug application

Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.

30 Mar 2010

Health industry will see more patients with reform; Physicians give mixed reviews

The Atlanta Journal-Constitution: "The health care plan aims to send a wave of paying patients to hospitals, doctors and pharmacists." Expanded coverage will mean less uncompensated care, a boon to traditional safety-net hospitals, but also more Medicaid patients. Hospitals say Medicaid fees don't cover their costs, so that influx could hurt the bottom line.

30 Mar 2010

Astellas Pharma, OSIP enter into confidentiality agreement

Astellas Pharma Inc. confirmed today that it has entered into a confidentiality agreement with OSI Pharmaceuticals, Inc. Under the agreement, OSI will provide Astellas with access to certain non-public information. This follows Astellas' approach to OSI after OSI's announcement that its board of directors had instructed its management and financial advisors to contact interested third parties regarding a potential transaction.

30 Mar 2010

Trius Therapeutics' Phase 1 trial establishes safety and tolerability of IV torezolid phosphate for MRSA

Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).

30 Mar 2010

Democrats reflect on importance of reconciliation in health bill strategy

Reconciliation proved critical to health care reform passage, The New York Times reports: "Just a few months into his first term in 1993, President Bill Clinton went to Senator Robert C. Byrd of West Virginia, the protector of Senate rules, to ask permission to use a fast-track budget process known as reconciliation to enact a bold health care overhaul.' At that time, Clinton got neither consent nor the passage of a health care law.

30 Mar 2010

Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.S.

Alcon, the world's leader in eye care, announced today that it received regulatory approval and finalized the acquisition of the rights in the United States for DUREZOL™ emulsion and the global rights, excluding Latin America, for ZYCLORIN™ from Sirion Therapeutics, Inc.

30 Mar 2010

Industry groups, lobbying firms gain from health overhaul

The Associated Press: Under the new health care law, "pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth." Ramsey Baghdadi, a Washington health policy analyst, "projects a $30 billion, 10-year net gain for the industry. 'I don't see how they could have done much better,'" he said.

29 Mar 2010

Cutting off coverage? An examination of a case in California

The Huffington Post Investigative Fund on the case of Heather Galeotti, a woman in a coma after being hit by a car: "[I]n July 2007, five months into Galeotti's treatment, Kaiser [Permanente] stunned the family with a letter. The Galeottis would have to find another way to pay the bills. Based on information received from her father's employer, Kaiser said that the young woman's coverage had not been in effect when she was hit."

29 Mar 2010

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

29 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Also in Global Health News: H1N1; USAID's Global Pulse; Rotavirus vaccine; Uzbek doctors; Zimbabwe development; Malaria vaccine

WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).

29 Mar 2010

Siemens Healthcare Diagnostics announces new contract with Premier Purchasing Partners

Siemens Healthcare Diagnostics announces a new three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of Premier Inc., that includes Siemens powerful integrated diagnostic systems, several specialty diagnostic instruments, and a comprehensive menu of diagnostic tests for Premier's more than 2,300 member hospitals and 64,000 additional healthcare sites.

29 Mar 2010

ZHF I repays outstanding U.S. SBA guaranteed debentures

Ziegler Healthcare Fund I (ZHF I), an affiliate of Contemporary Healthcare Capital company, recently achieved a major milestone as a Small Business Investment Company (SBIC) when the firm repaid its outstanding United States Small Business Administration guaranteed debentures.

29 Mar 2010

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation today announced a partnership with Rothman Healthcare Research to build its Patient Condition Tracker software solution on the Helios by Eclipsys™ platform.

29 Mar 2010

GSK offers free vaccines for low income adults without insurance coverage

GlaxoSmithKline today announced the launch of the GSK Vaccines Access Program, which will provide the company's adult vaccines free of charge to eligible, low income individuals who do not have insurance coverage for vaccines. The program will cover the company's FDA-approved vaccines for Hepatitis A, Hepatitis B, tetanus, diphtheria, and pertussis for eligible persons ages 19 and older.

29 Mar 2010

Unrestricted availability of food can trigger overconsumption and obesity

Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health.

29 Mar 2010

GHX to cut another $5 billion from healthcare costs

In the debate over healthcare reform, the healthcare supply chain has been largely overlooked as an effective way to reduce the cost of healthcare. Yet GHX and a collaborative community of healthcare providers, manufacturers, distributors and group purchasing organizations (GPOs) have already documented more than $1.3 billion in savings, and are on track to cut another $5 billion from the cost of healthcare over the next 5 years.

29 Mar 2010

$Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device$

Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device

Vivakor, Inc. announced today that it has partnered with Eco Scientific Lab, Inc. for commercialization of two Vivakor products. The first is the phytochemical rich nutraceutical beverage, VIVABlend™, developed exclusively by Vivakor and currently being sold in the direct to consumer market by Regeneca International, Inc.

29 Mar 2010

Medical News

Researchers to study health literacy among Indigenous people living with cardiovascular disease

Shinseki tries to squelch rumors about health reform and Vets

Cephalon receives FDA Complete Response Letter for NUVIGIL supplemental new drug application

Health industry will see more patients with reform; Physicians give mixed reviews

Astellas Pharma, OSIP enter into confidentiality agreement

Trius Therapeutics' Phase 1 trial establishes safety and tolerability of IV torezolid phosphate for MRSA

Democrats reflect on importance of reconciliation in health bill strategy

Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.S.

Industry groups, lobbying firms gain from health overhaul

Cutting off coverage? An examination of a case in California

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Also in Global Health News: H1N1; USAID's Global Pulse; Rotavirus vaccine; Uzbek doctors; Zimbabwe development; Malaria vaccine

Siemens Healthcare Diagnostics announces new contract with Premier Purchasing Partners

ZHF I repays outstanding U.S. SBA guaranteed debentures

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

GSK offers free vaccines for low income adults without insurance coverage

Unrestricted availability of food can trigger overconsumption and obesity

GHX to cut another $5 billion from healthcare costs

Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News